SALT LAKE CITY, Nov. 09, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in precision medicine, announced that its Myriad Autoimmune business unit will present new data ...
Please provide your email address to receive an email when new articles are posted on . The Vectra multi-biomarker disease score, as determined by the Vectra molecular blood test, is a more successful ...
SALT LAKE CITY, Nov. 20, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in molecular diagnostics and precision medicine, announced that the American College of ...
Myriad Genetics, Inc.MYGN recently came up with a favorable study result on the company's adjusted Vectra score. Published in the journal Rheumatology, this study announced results from a large ...
Please provide your email address to receive an email when new articles are posted on . The American College of Rheumatology has added the Vectra blood test, developed by Myriad Genetics, to its list ...
Crescendo Bioscience®, Inc. has announced the online publication of results validating the performance of Vectra™ DA to measure rheumatoid arthritis (RA) disease activity in Arthritis Care & Research, ...
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has entered into a definitive agreement to acquire select operating assets and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results